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Introduction
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), 
remains the leading cause of death from an infectious agent (Global 
Tuberculosis Report, WHO, 2018 (1). Although treatable with 
antibiotics, there is an urgent need to develop an effective vaccine 
against TB because of the challenges of diagnosis, the long duration 
of treatment, and the rise of drug-resistant strains. Protection from 
disease in 90% of infected individuals demonstrates that immune 
responses can cope with Mtb infection (2). Bacille Calmette-Guérin 
(BCG), the current vaccine, protects infants from disseminated TB 
and may enhance immunity if readministered, or when given by 
intravenous or aerosol vaccination routes. In addition, BCG can be 
improved upon, as shown by the recent phase IIb trial of the novel 
M72/AS01E vaccine (3). These data offer hope that an improved TB 
vaccine is possible, but more potent candidates are needed.
The potential to harness donor-unrestricted T cells (DURTs) 
and other unconventional T cells to boost anti-TB immunity is 
of great interest to the vaccine field (4). Conventional T cells are 
“restricted” to recognizing peptide antigens bound to MHC mole-
cules that are highly polymorphic between unrelated individuals. 
Unconventional T cells, in contrast, generally recognize antigens 
bound to nonpolymorphic antigen-presenting molecules and are 
thus “unrestricted” by the host genotype (5). In addition, they typ-
ically target conserved pathogen-derived lipids and metabolites, 
which are less likely to mutate and be lost as immune targets.
DURTs described to date include mucosa-associated invari-
ant T cells (MAITs), HLA-E–restricted T cells, invariant NK T cells 
(iNKTs), and group 1 CD1–restricted T cells including germline- 
encoded mycolyl lipid–reactive T cells (GEMs). MAITs, iNKTs, and 
GEMs all recognize their cognate antigens (bacterial metabolites 
bound to MR-1 or lipid-derived ligands bound to CD1a, -b, -c, or 
-d) via αβ T cell receptors (TCRs). In addition, γδ T cells are a major 
class of unconventional T cells that recognize a variety of peptide 
and nonpeptide antigens presented by CD1 or other nonpolymor-
phic molecules via the γδ TCR (6, 7)
Many studies indicate that these unconventional T cells play an 
important protective role in TB, particularly during early infection 
(8–10). For example, γδ T cells recognize Mtb antigens, respond to 
BCG vaccination, suppress mycobacterial growth, and confer pro-
tection when adoptively transferred, and expansion of pulmonary 
γδ T cells by vaccination reduces disease pathology in nonhuman 
primates (NHPs) (11). Likewise, CD1-restricted DURTs recognize 
mycobacterial lipids, transfer of mycolic acid–specific CD1b- 
restricted T cells confers protection against TB to humanized 
mice, and airway LAM-responsive, CD1b-restricted T cells are 
associated with protection from disease in TB-exposed humans 
(12–14). MR1-KO mice, which lack MAITs, show a reduced ability 
to control initial infection (15), and polymorphism associated with 
reduced MR1 expression in humans is linked to TB susceptibility 
and meningeal disease (16). This anti-TB activity of DURTs and 
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ever, little is known about the lung DURT and γδ T cell response in 
human TB infection, as most studies have focused on blood. The 
existence of noncirculating tissue-resident memory T cells (Trms) 
(24) demonstrates that T cell responses in the blood and tissue do 
not always mirror each other. Therefore, it is necessary to charac-
terize DURT and γδ T cell responses in the lung during active TB 
infection to understand the potential contribution of nonclassical 
T cell subsets to immunity.
Unlike conventional T cells, DURTs use TCRs that are less 
diverse and frequently shared between individuals, which may 
result from the nonpolymorphic nature of the presenting mole-
cules and the relatively restricted nature of their antigens. This is 
particularly true for TCRα chains of DURTs, which are frequently 
formed by canonical rearrangements of Vα (TRAV) and Jα (TRAJ) 
gene segments (5). For example, MAITs exclusively use TRAV1-
02 paired with TRAJ33 (25, 26), and iNKTs use an invariant TCRα 
chain formed by TRAV10 joining to TRAJ18 (Table 1 and see Sup-
γδ T cells and the universal nature of their presenting molecules 
make the highly conserved antigens they recognize attractive vac-
cine targets (9, 16, 17). Another promising feature of DURTs and 
some γδ subsets is their apparent preference to migrate to and 
reside at mucosal sites. Promotion of lung residency of TB-specific 
T cells is thought to be essential for the protective activity of these 
cells, and this protection may even be highly localized within the 
particular tissue, as T cell control can vary among different lesions 
within the same lung (18). This may also explain why it is challeng-
ing to identify strong T cell correlates of protection in the blood 
(19–22). MAITs, for example, are highly enriched at mucosal bar-
riers, including in the lung, where they comprise 2%–4% of T cells 
(8). Several infections, including TB, are associated with a loss of 
MAITs from the circulation, which could result from recruitment 
to infected tissues (8). Likewise, pulmonary CD1–restricted αβ T 
cells and γδ T cells isolated from Mtb-infected subjects rapidly 
migrate back to the lung after intravenous infusion (13, 23). How-
Table 1. Demographics of the study participants 
 Active TB Previous TB Cancer HCs
Characteristic n = 22 n = 6 n = 3 n = 12
Sex, no. (%)  
 Female 8 (36) 4 (66.7) 1 (33.3) 8 (66.7)
 Male 14 (64) 2 (33.3) 2 (66.7) 4 (33.3)
Age (yr), median (range)     
 All subjects 37.5 (18–55) 41 (32–68) 61 (58–66) 35 (22–55)
 Female 35.5 (22–55) 49 (37–68) 58 (58–58) 33 (22–55)
 Male 37.5 (18–55) 33 (32–34) 63.5 (61–66) 37.5 (25–42)
HIV, no. (%)     
 Positive 7 (32) 4 (66.7) 0 (0) 0 (0)
  CD4 count; mean (range)A 484 (166–814) 300 (30–785)   
  Viral loadB  
  Suppressed, no. (%) 4 (57) 4 (100)   
  Unsuppressed, no. (%) 15,489 and 670; 2 (29) 0  
  ART regimen Odiumune/Atrioza/Tribuss
 Negative 15 (68) 2 (33.3) 3 (100) 12 (100)
Other lung pathology,C no. (%)     
 Cavitary lung 11 (50) 1 (17) 1 (33) NA
 Bronchiectasis 6 (27) 2 (33.3)  NA
 Mycetoma 4 (18) 0 NA
 Fibrosis 0 1 (17)  NA
 Aspergilloma 0 1 (17) NA
 Interstitial lung disease 9 (41) 0  NA
 Consolidation/nodules 10 (45) 0 NA
Smoking history, no. (%)     
 Smokers 5 (23) 1 (17) 1 (8)
 Nonsmokers 15 (77) 5 (83)  11 (92)
TB treatment outcomes, no. (%)  
 Drug-susceptible 15 (68) 6 (100)   
 MDR TB 3 (14)  
 XDR TB 1 (4)    
 Treatment-naive 3 (14)  
Treatment regimen Combination therapyD    
ACD4 count unavailable for 2 HIV-infected individuals (both with active TB). BViral load value for 1 active TB not available; suppressed, <40 copies/mL. 
CSome individuals had more than 1 lung pathology. DCombination of any 2 or 3 of these drugs: Rifafour, pyradoxine, streptomycin, Rifinah, tenzidone, 
pyrazinamide, isoniazid, kanamycin, moxifloxacin, or clofazimine. MDR, multidrug resistant; XDR, extensively drug resistant.
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clonal than the HC blood TCR repertoire (Figure 1D). HIV status 
affected blood TCR clonality, which was quite variable among 
lung cohort subjects (Figure 1E). For HIVneg subjects, TCR clon-
ality was significantly higher in lung than in blood (Figure 1F). 
HIV infection was associated with higher clonality in the blood 
and lungs of HIVpos subjects compared with HIVneg subjects, which 
might reflect expansion of the HIV-specific T cell and/or contrac-
tion of the TCR repertoire through CD4 depletion. These findings 
support the idea that the lung is enriched with clonally expanded 
T cells compared with PBMCs because of recruitment and expan-
sion of antigen-specific T cells at the site of disease (29).
Frequency of DURTs and γδ T cells during active TB. To determine 
the frequency of GEMs, MAITs, iNKTs, and γδ T cells, we identi-
fied TCRα/δ features representing different T cell subsets (Table 
2). First, we confirmed the quantitative nature of our approach by 
analyzing the TCR repertoire of HCs using sequencing and flow 
cytometry. γδ T cells were identified with a pan-γδ TCR antibody 
and subdivided on the basis of Vδ1 or Vδ2. We classified MAITs 
according to expression of Vα7.2 (TRAV1-02), CD161, and CD26 
(16). The frequency of γδ and MAIT TCRs in the same samples was 
based on TCR characteristics (Table 2). We found a strong correla-
tion between the TCR frequencies, as determined by flow cytome-
try and sequencing (Figure 2A). Thus, high-throughput TCR analy-
sis represents a valid method for enumerating DURT subsets.
We next determined whether the frequency of unconventional 
T cells varied between HCs and subjects with active TB. Blood 
from HCs had a reproducible hierarchy, with the frequency of γδ 
T cells > MAITs > iNKTs > GEMs (Figure 2B). Although this hierar-
chy was preserved during active TB, the frequencies of GEMs and 
MAITs were significantly lower in the blood of subjects with active 
TB, independent of HIV status (Figure 2B).
To determine whether DURT TCRs were enriched in infected 
lung tissue compared with blood, we analyzed lung TCRs from 
HIVneg subjects with active TB, as HIV can affect the frequency 
of some DURTs (30–33). We found that αβ DURTs and γδ TCRs 
accounted for nearly 9% of TCR sequences in the blood of HCs, 
which was slightly higher than for HIVneg subjects with active TB 
(Figure 2C). The frequency of αβ DURTs and γδ TCRs was even lower 
(~4%) in the 17 lung lesions from 9 HIVneg subjects with active TB, 
arguing against a general enrichment of DURTs in the lung. These 
differences were driven by reductions in the abundance of Vδ2 
TCRs. The frequency TCRDV2, which is the dominant Vδ gene 
used by γδ T cells in the blood, was 2.7-fold lower in the lungs of 
HIVneg subjects with active TB compared with matched blood sam-
ples or blood from HCs (P < 0.0001) (Figure 2D). The frequency 
of MAIT TCRs in the blood and lungs of subjects with active TB 
was also significantly lower than in the blood of HCs. In contrast, 
the frequency of iNKTs was similar in all 3 groups. The frequency 
of GEM TCRs was not significantly different between groups, 
although these TCRs were present at a very low frequency in the 
lungs and were undetectable in some subjects. Finally, distribu-
tion of the 4 T cell subsets was similar in the 3 types of lung lesions 
examined (Figure 2E), indicating that there was no association 
between DURT frequency and disease severity in our cohort. Thus, 
all 4 types of DURT subsets were identified in the lungs of subjects 
with active TB. Next, we explored differences in the TCR reper-
toires of these different DURT subsets.
plemental material; supplemental material available online with 
this article; https://doi.org/10.1172/JCI130711DS1). Importantly, 
both subsets are expanded in all humans, even at a very young 
age (5). Likewise, GEMs use TRAV1-02 and are widely detected. 
Indeed, a strategy to discover new DURTs involves the identifi-
cation of expanded and highly shared TCRα chains through TCR 
sequencing (27). Finally, although γδ TCR diversity is similar to 
that of αβ T cells, it is largely achieved through extensive junctional 
diversity, as γδ TCRs have a reduced number of V and J gene seg-
ments, with an overwhelming bias toward Vγ9 paired with Vδ2 (7).
In this study, we exploited the distinctive and highly shared 
nature of DURTs and γδ TCRs to determine the involvement of 
these unconventional T cells in the immune response to TB infec-
tion using a global TCR-sequencing approach. We studied a cohort 
of HIV-infected and uninfected subjects undergoing surgical lung 
resection to treat ongoing TB or the sequela of treated infection and 
determined the distribution, frequency, and characteristics of DURT 
and γδ TCR clonotypes in blood and matched lung tissue from sub-
jects with active TB or previous TB disease. In addition, we assessed 
the impact of HIV coinfection on the DURT and γδ TCR repertoire.
Results
Patient cohort and their TCR repertoire. To study immunity at the 
site of disease, we recruited 31 subjects undergoing partial lung 
resection for clinical indications. HIV-coinfected (HIVpos) or HIV- 
seronegative (HIVneg) subjects were classified as having active TB 
or prior TB on the basis of clinical findings (Table 1). Individual 
lung tissue blocks from severely diseased (type A), moderately 
affected (type B), or less-severely affected (type C) lung areas 
were categorized by the operating surgeon and informed by pre-
operative imaging studies. Representative lung immunohistology 
showed lymphocytic infiltrates consisting of CD4, CD8, and CD68 
staining and necrosis (particularly in type A lesions) (Figure 1A). 
The considerable variability between individuals prevented the 
categorization of subjects on the basis of lung pathology (e.g., cav-
itary disease, calcification). Importantly, we detected extensive 
lung involvement in all lung samples including type C lesions.
We determined the TCRα/δ rearrangements by high-through-
put sequencing of 81 samples of blood, lung, and sputum from 
the 31 subjects described and of blood from 12 healthy (disease- 
free) controls (HCs) (28, 29). TCR sequences corresponding to 
more than 29 million templates, which encoded 224,000 unique 
TCRα/δ aa sequences, were analyzed, and more than half were 
productive rearrangements (lung: 60% ± 2%; PBMCs: 57% ± 2%). 
Deep sequencing of PBMC samples acquired 280,000 ± 114,000 
productive TCRα/δ sequences, whereas survey-level sequenc-
ing of lung samples obtained 124,000 ± 75,000. Blood from HCs 
contained more unique productive rearrangements than did blood 
from the lung cohort (132,000 ± 36,000 vs. 116,000 ± 60,000) 
(Figure 1B). Fewer unique TCRα/δ sequences were identified 
in lung (33,000 ± 17,000) than in blood, in part because survey- 
level sequencing was used in the lung. HIV status had no significant 
effect on the number of productive rearrangements (Figure 1C).
We examined TCR clonality, which represents the tendency of 
a T cell population to be dominated by clonally expanded T cells 
and can signify antigen-driven responses (Supplemental materi-
al). We found that the lung TCR repertoire was significantly more 
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In addition to CD1d-restricted T cells (i.e., NKTs), T cells 
that are restricted to group 1 (CD1a, -b, and -c) recognize lipid 
and glycolipids from the cell wall of Mtb (5), although only a 
handful with validated CD1 restriction and known antigen 
specificity have been sequenced (34, 35). Of these, we searched 
for 5 CDR3α sequences and identified 3, which were associated 
with the Jα originally described to be used by the lipid-reactive 
T cell clones (Supplemental Figure 1). These sequences used a 
diverse Vα gene and were present at low frequencies.
CD1b-restricted T cells that recognize glucose monomyco-
late (GMM) share TCRα genes and CDR3α motifs (5, 36, 37). The 
CD1b-restricted, GMM-specific T cell clone 18 uses TRAV01-02 
and TRAJ09, with the CDR3α sequence CAVRNTGGFKTIF (37). 
This rearrangement is typical of GMM-specific CD1b-restricted T 
cells (i.e., GEMs) and may represent a semi-invariant rearrange-
CD1-restricted T cells in the lungs. Of the known CD1- 
restricted T cells, iNKTs are the best described. The Vα10/
Jα18 recombination that creates the invariant CDR3α of iNKTs 
(CVVSDRGSTLGRLYF) was detected in 78 of 79 samples (Fig-
ure 3A). The frequency of this iNKT TCRα was highly variable 
and ranged from 0.003% to 0.5% of the lung TCR repertoire. 
However, the iNKT TCRα was not significantly enriched in the 
lungs compared with the blood, nor did its frequency differ 
between HIVneg and HIVpos subjects (Figure 3A). Recognizing the 
significant individual-to-individual variation, we analyzed the 
distribution of iNKTs between paired blood and lung samples 
from subjects with active TB (Figure 3B) and found no discern-
able pattern. Thus, although iNKTs were present in the blood 
and lungs of nearly all subjects, we did not detect an increase in 
pulmonary iNKTs in any of the groups.
Figure 1. TCR sequences from human TB granulomas. (A) Representative immunohistology images of lung tissue from an HIVneg subject with active TB 
(original magnification, ×600) showing CD4+ve and CD8+ve T cells and CD68+ve macrophages. Samples from type A tissue, the most diseased area of the resected 
lung, had classic caseous granulomas with a distinct lymphocyte cuff and lymphocyte aggregates. Samples from types B and C, from less diseased tissue, 
show lymphocytic infiltrations and uninvolved alveoli. (B) Number of unique productive TCRα and TCRδ rearrangements obtained from deep-level (blood) or 
survey-level (lung) sequencing. Each point represents a unique subject. Color identifies the clinical status, grouped by tissue and lung lesion type (i.e., type A, 
B, or C). (C) Number of unique productive rearrangements obtained from blood or lung tissue from HIVneg versus seropositive subjects (HIVpos) with active or 
prior TB. (D) Clonality of the productive TCRα and TCRδ rearrangements (as in B). (E) Productive clonality calculated for TCRs identified in blood or lung from 
HIVneg versus HIVpos subjects with active or prior TB. (F) Effect of HIV status on TCR clonality during active TB. Error bars indicate the median. *P < 0.05, **P < 
0.01, ***P < 0.001, and ****P < 0.0001, by Kruskal-Wallis 1-way ANOVA with Dunn’s multiple comparisons test (B–F).
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lung were CAVRDTGGFKTIF (n = 19 of 49), CAVRGTGGFKTIF 
(n = 12 of 49), and CAVRNTGGFKTIF (n = 9 of 49) (Figure 3C). 
Although CAVRDTGGFKTIF was the most frequently detected, 
CAVLDTGGFKTIF had the greatest aggregate frequency because 
it was expanded in subject 09-213. Although GEM TCRs were fre-
ment (37). This possibility is strengthened by the detection of the 
CAV[R/L]xTGGFKTIF CDR3α motif among PBMCs from Mtb- 
infected subjects and among T cells enriched using GMM-CD1b 
tetramers (38). Among the TRAV01-02/TRAJ09 rearrangements 
with this motif, the most frequently detected CDR3α sequences in 
Table 2. TCR usage by DURTs and γδ T cells     
 
GEMEXT iNKTs MAITEXT MAIT-like γδ-TCRs
Vα TRAV01-02 TRAV10 TRAV01-02 TRAV01-02 Vδ1(TRDV1), Vδ2(TRDV2), 
Vδ3(TRDV3), Vδ4(TRAV14), 
Vδ5(TRAV23), Vδ6(TRAV29), 
Vδ7(TRAV36), Vδ8(TRAV38) 
Jα TRAJ9 TRAJ18 TRAJ33 TRAJ33 Jδ1, -2, -3, -4
CDR3α length 13 15 12 11–15 Variable
Number of unique CDR3α 
sequences
40 1 8 39 Multiple
Consensus sequence CAVRxTGGFKTIF, 
CAVLxTGGFKTIF, x = any aa
NA CAVxDSNYQLIW, x = R, A, K, L, 
M, S, T, V
MAIT score = 1 NA
References (41, 42) (26) (26) http://www.cbs.dtu.dk/
services/MAIT_Match/
IMGT.org
Sequences CAVRATGGFKTIF 
CAVRRTGGFKTIF 
CAVRDTGGFKTIF 
CAVRCTGGFKTIF 
CAVRETGGFKTIF 
CAVRQTGGFKTIF 
CAVRGTGGFKTIF 
CAVRHTGGFKTIF 
CAVRITGGFKTIF 
CAVRLTGGFKTIF 
CAVRKTGGFKTIF 
CAVRMTGGFKTIF 
CAVRNTGGFKTIF 
CAVRFTGGFKTIF 
CAVRPTGGFKTIF 
CAVRSTGGFKTIF 
CAVRTTGGFKTIF 
CAVRWTGGFKTIF 
CAVRYTGGFKTIF 
CAVRVTGGFKTIF 
CAVLATGGFKTIF 
CAVLRTGGFKTIF 
CAVLNTGGFKTIF 
CAVLDTGGFKTIF 
CAVLCTGGFKTIF 
CAVLETGGFKTIF 
CAVLQTGGFKTIF 
CAVLGTGGFKTIF 
CAVLHTGGFKTIF 
CAVLITGGFKTIF 
CAVLLTGGFKTIF 
CAVLKTGGFKTIF 
CAVLMTGGFKTIF 
CAVLFTGGFKTIF 
CAVLPTGGFKTIF 
CAVLSTGGFKTIF 
CAVLTTGGFKTIF 
CAVLWTGGFKTIF 
CAVLYTGGFKTIF 
CAVLVTGGFKTIF
CVVSDRGSTLGRLYF CAVRDSNYQLIW 
CAVADSNYQLIW 
CAVKDSNYQLIW 
CAVLDSNYQLIW 
CAVMDSNYQLIW 
CAVSDSNYQLIW 
CAVTDSNYQLIW
CAVVDSNYQLIW
CAALDSNYQLIW 
CAAMDSNYQLIW 
CAASDSNYQLIW 
CAASKAAGNKLTF 
CAAVDSNYQLIW 
CAFMDSNYQLIW 
CAGLDSNYQLIW 
CAGMDSNYQLIW 
CAIMDSNYQLIW 
CAPLDSNYQLIW 
CAPMDSNYQLIW 
CAPSGSARQLTF 
CASMDSNYQLIW 
CASMDSSYKLIF 
CATMDSNYQLIW 
CAVESNSGYALNF 
CAVGDSNYQLIW 
CAVGYSSASKIIF 
CAVIDSNYQLIW 
CAVLDSSYKLIF 
CAVLNTGGFKTIF 
CAVLSNDYKLSF 
CAVMDSSYKLIF 
CAVNNNNDMRF 
CAVPNSGGSNYKLTF 
CAVPSGGSYIPTF 
CAVQDSNYQLIW 
CAVRDGDYKLSF 
CAVRDGNYQLIW 
CAVRDNDYKLSF 
CAVRDNFNKFYF 
CAVRDRDYKLSF 
CAVRDRDYQLIW 
CAVRDSDYKLSF 
CAVRDSSYKLIF 
CAVRDTGFQKLVF 
CAVRRDDKIIF 
CAVSDSSYKLIF 
CVPMDSNYQLIW
NA
The sequences in bold represent the prototypical or original sequences for the class of invariant TCR.
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quently detected within our cohort, their abundance was generally 
low, and they did not differ between disease groups (Figure 3D).
In addition to the TRAV01-02+ GEM-like T cells, we also 
identified non–TRAV01-02 clonotypes with a CDR3α sequence 
of CAV[R/L]xTGGFKTIF, all of which used the TRAJ09 gene. 
These GEM-like TCRα sequences were detected in the blood 
of all subjects (n = 39 of 39) and in most lung samples (n = 47 of 
49), consistent with the highly shared nature of other non–MHC- 
restricted TCRs (Figure 3E and Supplemental Figure 2). Similar 
to TRAV01-02 clonotypes, CAVRDTGGFKTIF, CAVLNTGGFK-
TIF, CAVRNTGGFKTIF, and CAVRGTGGFKTIF were frequently 
detected and abundant. We analyzed the lung cohort sam-
ples and found that the GEM-like TCRs most commonly used 
TRAV03-1 instead of TRAV01-02 (TRAV20 was predominantly 
used by a single subject) (Figure 4, A and B). These data led us 
to consider the relative abundance of CAV[R/L]xTGGFKTIF 
sequences among TRAV01-02 versus non–TRAV01-02 TCRs. 
These sequences were more frequent among the non–TRAV01-
02 TCRs, and certain CDR3α sequences were only found among 
the non–TRAV01-02 TCRs (Figure 4C). The frequency of lung T 
cells with the CAV[R/L]xTGGFKTIF motif was greater among 
the non–TRAV01-02 TCRs than the TRAV01-02 TCRs, some-
times by more than 100-fold in the 3 largest patient groups from 
the lung cohort (Figure 4D). Finally, the frequency of GEM-like 
TCRs was significantly increased in the lungs of HIVpos subjects 
with prior TB compared with those with active TB (Figure 4D). 
These data suggest that HIV coinfection, per se, does not deplete 
GEM-like TCRs in the lung, as occurs in the blood. Thus, these 
data establish that CD1-restricted T cells are present in the lungs 
during human TB infection. We propose that the non–TRAV01-
02 TCRs that encode the CAV[R/L]xTGGFKTIF motif may rep-
resent a large population of GMM-specific CD1-restricted T cells.
MAITs in the lung. MAITs are semi-invariant T cells defined by 
their TCRα chain, which is a recombination of Vα1-02 with Jα33, 
resulting in the CDR3α sequence CAVxDSNYQLIW and referred 
to hereafter as MAITEXT (Table 2) (26). The frequency of MAITs in 
blood, as measured by flow cytometry, is reduced during TB, with 
or without HIV coinfection (30, 31, 39). We observed a reduction 
Figure 2. Next-generation sequencing 
summary for the human TCRA/D locus. 
(A) Frequency of Vδ1, Vδ2, γδ T cells and 
MAITs as determined by TCR sequencing 
(y axis) or flow cytometry (x axis, fraction 
of CD3+ T cells) in blood from HCs. (B) 
Percentage of γδ T cells, MAITs, iNKTs, and 
GEMs in blood from HCs, HIVpos subjects, 
and HIVneg subjects with active TB. (C) 
Percentage of DURTs in blood from HCs 
(n = 12) and in blood (n = 11) or lung tissue 
(n = 17) from HIVpos subjects with active 
pulmonary TB. The TCRδ sequences 
encoded by the Vδ1, Vδ2, or Vδ3 or Vδ* 
(Vδ4+Vδ5+Vδ6+Vδ7+Vδ8) are identified 
by different shades of red. The non-
DURTs are defined as “conventional.” (D) 
Percentage of Vδ1, Vδ2, or Vδ3, MAIT, iNKT, 
and GEM T cells in blood from HCs and 
blood and lung tissue from HIVneg subjects 
with active pulmonary TB. (E) Percentage 
of total GEM, MAITs, iNKT, and γδ T cells 
in lung lesion types A, B, and C. *P < 0.05, 
**P < 0.01, ***P < 0.001, and ****P < 
0.0001, by Kruskal-Wallis 1-way ANOVA 
with Dunn’s multiple comparisons test (B) 
and 2-way ANOVA with Tukey’s multiple 
comparisons test (D and E).
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in MAIT TCR frequency during active TB, without any reciprocal 
enrichment in the lungs (Figure 2, B and D). We detected a trend 
toward lower MAIT cell frequencies in subjects with HIV coin-
fection, however, it was not statistically significant. Moreover, 
we found that MAITs were significantly elevated in the lungs of 
HIVpos subjects with prior TB, suggesting that, as with GEM-like T 
cells, the loss of MAITs from lung tissue is not a consistent feature 
of HIV infection (Figure 5A). As with iNKTs, we did not observe 
marked differences in the frequency of MAITs between paired 
blood and lung samples (Figure 5, A and B).
Since the antigens that MR1-restricted MAITs recognize are 
still being defined, the definition of what constitutes a MAIT TCR 
is still in flux (16). We extended our definition of MAITs to include 
TCRs that scored 1.0 on the MAIT match, although not all of these 
have been confirmed to be MR1 restricted. Given this expanded 
definition of MAIT-like cells, we used 47 CDR3α sequences 
Figure 3. CD1-restricted T cells in blood and lung during active TB. (A) The frequency of iNKTs in blood (open circles) compared with lung (solid circles) 
among 5 clinical populations. (B) iNKT cell frequency in paired lung and blood samples, stratified by HIV status for subjects with active TB. Each line 
represents a single individual. (C) Using a consensus definition of GEM TCRα (Vα1-02, Jα9, CDR3α=CAV(R/L)xTGGFKTIF), GEMs were identified in lung 
tissue. The 6 most frequently detected clonotypes are shown, with their total relative abundance in the aggregated lung TCR data set. (D) Frequency of 
GEMs in blood (open circles) versus lung tissue (solid circles) among 5 clinical populations. (E) Clonotypes encoded by TRAV01-2 with the CDR3α CAV(R/L)
xTGGFKTIF were identified in HCs (blood, top) and subjects in the lung cohort (blood, second graph; lung, third graph). Non–TRAV01-2 clonotypes encoding 
the CAV(R/L)xTGGFKTIF CDR3α were identified in lung (bottom graph). A frequency of 0.0000001 was assigned to clonotypes not detected. Dotted lines 
indicate a productive frequency of 0.05%. Colored violins indicate the most frequently detected lung clonotypes. Red lines indicate the median and blue 
lines the quartiles.
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blood (Figure 6, C and D). Although Vδ2 was clearly dominant in 
HCs, Vδ2 and Vδ1 were codominant in the blood of subjects with 
active TB (Figure 6E). The dominant Vδ gene in the lung was 
Vδ1, and this difference was highly significant in HIVneg subjects 
with active TB, who had an increased frequency of Vδ1/Jδ1 rear-
rangements and a reciprocal reduction in the relative amount of 
Vδ2/Jδ1 (Figure 6, C–E). These data suggest that the γδ T cell 
repertoire is highly skewed in lungs compared with blood.
Identification of enriched and abundant TCRδ clonotypes in 
the lung. Having identified 32,000 unique TCRδ clonotypes, we 
next identified TCRδs that were overrepresented in the infected 
lung. Figure 7A highlights 2 representative HIVneg individuals 
with active TB (subjects 09-231 and 09-236). For lung samples 
from subjects 09-231A and 09-231C, 2.9% and 8.4% of the 
unique TCRδ clonotypes accounted for 50% of the total TCRδ 
sequences. Similarly, 4.3% and 0.6% of the unique TCRδs in 
lung samples from subjects 09-236A and 09-236C accounted 
for 50% of the total TCRδ sequences.
As the lung samples were surgical specimens, contamination 
with blood lymphocytes was unavoidable. We next assessed each 
TCRδ clonotype by comparing matched blood and lung samples. 
Remarkably, only 7% of the TCRδ clonotypes identified in the 
lung tissue were detected in blood, despite the fact that we used a 
greater sequencing depth for blood (Figure 7, B and C). The over-
lap was significantly greater for HIVpos individuals than for HIVneg 
individuals. Different lung samples taken from the same individ-
ual had largely nonoverlapping γδ TCR repertoires, indicating 
considerable heterogeneity within the lung tissue (Figure 7B).
We classified lung TCRδs into 4 groups: (a) unique to a single 
lung sample (sample-specific); (b) present in both lung samples 
but not in the blood (lung only); (c) shared between 1 lung sample 
and blood (paired); or (d) present in all lung samples and blood 
(shared) (Figure 7D). Most TCRδs were detected in a single lung 
sample. As many of these clonotypes were present at a low fre-
to query our data (Table 2). Importantly, not all of these were 
encoded by Vα1-02 or Jα33. We determined the frequencies of 
each MAITEXT or MAIT-like clonotype for each study subject (Fig-
ure 5C). We detected 7 of 8 MAITEXT clonotypes in the blood of 
all 12 HCs, and 4 were found in all blood and lung samples from 
the lung cohort (Figure 5C). Over half of the MAIT-like clono-
types were also detected in 100% of the HC blood samples, but 
at a lower frequency than the MAITEXT clonotypes (P < 0.0001, 
Mann-Whitney U test). In general, the MAIT-like clonotypes were 
highly shared among subjects in the lung cohort, which is consis-
tent with the behavior of these clonotypes as DURTs (Figure 5C). 
However, we did not observe enrichment of MAIT-like sequences 
in subjects with TB infection compared with HCs. Finally, we low-
ered the MAIT match score to 0.950–0.999 and identified 600 
CDR3α regions among our samples that resembled MAIT TCRs. 
Analysis of these TCRs did not reveal any private expansions in 
subjects with active TB, although, again, we did find some expan-
sions in HIVpos subjects with prior TB (Supplemental Figure 3).
Given that MAITEXT TCRα chains were more frequently 
detected in the lungs of HIVpos subjects with prior TB, we asked 
whether MAIT-like TCR clonotypes contributed to the lung 
MAIT repertoire in subjects with TB with or without HIV coinfec-
tion. We calculated the frequency of total MAITs (e.g., MAITEXT 
plus MAIT-like). As before, we found that HIVpos subjects with a 
history of prior TB had a greater frequency of total MAIT TCRs 
in their lung lesions compared with their blood (Figure 5D). This 
supports the conclusion that, unlike in blood, HIV infection does 
not deplete lung MAITs.
Vδ1/Jδ1 TCRs are prominent in the lungs of HIVneg subjects with 
TB. The frequency of γδ T cells (defined in Table 2 and Supple-
mental Figure 4) was lower in the lungs than in the blood only 
for HIVneg subjects with active TB (Figure 6A) but did not vary 
between lung samples (Figure 6B). We quantified Vδ gene use 
and found an overall reduction of Vδ2 in lung compared with 
Figure 4. CD1-restricted T cells in blood and 
lung during active TB. (A) TRAV diversity 
among TCRs from the lung cohort (blood, 
lung, sputum) with a consensus sequence 
of CAV(R/L)xTGGFKTIF. (B) TRAV diversity 
among TCRs from HC blood with a consensus  
sequence of CAV(R/L)xTGGFKTIF. (C) 
Relative abundance of CAV(R/L)xTGGFKTIF 
among TRAV01-2 and non–TRAV01-2 cell 
populations. Each circle represents a unique 
clonotype (solid circles represent the 6 most 
abundant clonotypes). (D) Frequency of GEM 
and GEM-like TCRs in lung tissue from 3 clini-
cal populations. Some statistical comparisons 
have been omitted for clarity. ***P < 0.001 
and ****P < 0.0001, by ordinary 2-way ANOVA 
with Tukey’s multiple comparisons test. Error 
bars indicate the median.
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The clonotypes that were detected only in the lung tissue had a 
higher overall frequency (Figure 7E, middle). Finally, the clono-
types that were detected in all samples contained TCRs that were 
enriched either in lung or blood (Figure 7E, right). To identify 
the TCRδ clonotypes that were both abundant and preferentially 
expressed in the lungs, we analyzed each of the 9 subjects with 
active TB separately, pooled the data, and identified 92 clono-
types with a productive frequency of greater than 0.05% and a 
lung/blood ratio of greater than 3 (Figure 7F). We found strong 
evidence of highly expanded γδ T cells within TB-infected tissue 
that were either absent, or present at a very low frequency, in the 
blood. In contrast to the other DURT TCRs, this is consistent with 
a significant lung-resident, nonrecirculating γδ T cell population in 
quency, they could represent blood contamination. In contrast, 
those unique clonotypes found in both lung samples were abun-
dant and overrepresented (Figure 7D). For example, for subjects 
09-231 and 09-236, 9.4% and 23% of unique TCRs were present 
in both lung samples; together, they accounted for 55% and 62%, 
respectively, of the total γδ TCRs (Figure 7D).
To formally identify overrepresented TCRδ clonotypes in the 
lung, we plotted the sum-total frequency for each clonotype in 
lung versus blood for TCRδs that were paired, lung-only, or shared 
(Figure 7E). The majority of paired clonotypes were present at a 
low frequency and generally more abundant in the blood than in 
the lung. This pattern is consistent with TCRδs that are present 
in the lungs as a result of blood contamination (Figure 7E, left). 
Figure 5. MAITs are expanded in the 
lungs of HIVpos subjects with a history 
of TB. (A) Frequency of extended 
MAITs (MAITExt, Table 2) in blood (open 
circles) and lung (solid circles) among 
5 clinical populations. (B) Frequency 
of MAITExt in paired lung and blood 
from subjects with active TB, stratified 
by HIV status. Each line represents a 
single individual. (C) MAITExt and MAIT-
like clonotypes in HC blood (top graph) 
and in samples form the lung cohort 
(blood, middle graph; lung, bottom 
graph). For clonotypes not detected, a 
frequency of 0.0000001 was assigned. 
Dotted line indicates a productive fre-
quency of 0.05%. MAITExt clonotypes 
are designated by violins in yellow. Red 
bars in indicate the median; blue bars 
indicate quartiles. (D) Frequency of 
total MAIT TCRs (MAITExt + MAIT-like) 
in blood (open circles) and lung (solid 
circles) among 5 clinical populations. 
*P < 0.05, by 2-way ANOVA with 
Sidak’s multiple comparisons test (A 
and D). Error bars indicate the median.
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found that there was less sharing than for the GEMs or MAITs 
(Figure 3, Figure 4, and Figure 5). Most TCRδ clonotypes were 
present in 1–4 samples, which corresponds to the number of sam-
ples per individual, although we detected 1 TCRδ clonotype in 16 
samples (Figure 8E). Evaluation of the TCR DNA rearrangements 
revealed that a single recombination event encoded each TCRδ 
clonotype in most cases. When more than 1 unique DNA rear-
rangement produced the same aa sequence, a single rearrange-
ment was dominant, and the others were detected at an extremely 
low frequency. Careful examination of these DNA sequences 
showed them to differ primarily in the 3′ region of the Vδ gene, 
consistent with PCR errors, but these sequences did not represent 
a distinct CDR3δ rearrangement (Supplemental Figure 5). How-
ever, we detected sharing of certain clonotypes between individ-
uals (Figure 8F).
Finally, although the subjects often had more than 1 expanded 
TCRδ clonotype in the lungs, generally 1 clonotype was dominant. 
Many of the 92 δTCR clonotypes had undergone major expansions 
in the lungs compared with the blood, and several were enriched 
by 10- to 2000-fold (Figure 9). Four of the clonotypes accounted 
for more than 1% of the total productive TCRs in the lung. Of the 
11 most abundant clonotypes, only 1 used the Vδ2 gene, 2 used Vδ3, 
and the remaining 9 used Vδ1. Thus, certain γδ T cells, with bias 
for Vδ1, undergo dramatic clonal expansion in the lungs during 
active TB infection and bear a greater similarity to conventional T 
cell responses than to DURTs.
the lungs. Importantly, many of TCRδs that were expanded in the 
lung would have been missed by studies that focused on γδ T cell 
responses in the blood.
Profiling of enriched and abundant TCRδ clonotypes in the 
lung. To ascertain whether the expanded TCRδs were over-
represented because of a specific response or a stochastic pro-
cess, we measured the distribution of CDR3δ lengths in blood 
and lung (Supplemental material). The blood and lung CDR3δ 
length distribution was similar, with a peak of 54–57 nucleo-
tides (Figure 8A, left). In contrast, the 92 enriched and abun-
dant clonotypes had skewed CDR3δ lengths with discrete peaks 
at 45, 57, and 66 nucleotides. Reanalysis of the distribution of 
CDR3δ lengths on the basis of abundance revealed a more pro-
nounced skewing for the 92 enriched and abundant lung TCRδs 
(Figure 8A, right). Although these 92 clones only represent 1% 
of the unique lung TCRδ clonotypes, they account for half of 
all γδ T cells detected among the 49 lung samples. The Vδ and 
Jδ genes used by these 92 TCRs were biased and used Vδ1Jδ1 
and Vδ1Jδ3 more frequently compared with blood (compare 
Figure 8B with Figure 6E). We determined whether a motif was 
present for CDR3δs with a length of 57 nucleotides. We found 
that leucines and prolines were modestly enriched, but no clear 
motif was evident (Figure 8C).
The 92 TCRδs were similarly distributed among HIVneg or 
HIVpos subjects with active TB (Figure 8D). We next determined 
whether there was sharing of unique TCRδs between subjects and 
Figure 6. Distribution of unique TCRδ clo-
notypes. (A) Frequency of γδ T cells (Table 2) 
in blood (open circles) and lung (solid circles) 
among 5 clinical populations. (B) Frequency 
of γδ T cells in paired lung and blood samples 
from subjects with active TB were strati-
fied by HIV status. Each line represents a 
single individual. (C) Vδ1, Vδ2, Vδ3, or Vδ* 
(Vδ4+Vδ5+Vδ6+Vδ7+Vδ8) use for each lung 
(top graph) or blood (bottom graph) sample. 
The clinical status of each subject is shown. 
(D) Vδ1, Vδ2, or Vδ3 use by T cells from the 
blood of HCs versus blood or lung tissue of 
HIVneg subjects with active pulmonary TB. 
Some statistical comparisons have been 
omitted for clarity. (E) Pairing analysis of 
Vδ1, Vδ2, or Vδ3 with Jδ1, Jδ2, Jδ3, or Jδ4 in 
blood from HCs compared with blood and 
lung tissue from HIVneg subjects with active 
pulmonary TB. *P < 0.05, **P < 0.01, ***P < 
0.001, and ****P < 0.0001, by 2-way ANOVA 
with Sidak’s (A and F) or Tukey’s (E) multiple 
comparisons test. Error bars indicate the 
median; data represent the mean ± SEM.
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DURT and γδ T cell repertoire in blood and matched lung tissue 
from TB-infected individuals. Our ability to analyze TB-infected 
human lung tissue is important, as, to our knowledge, this is the 
first report to directly examine these DURT subsets at the site of 
disease in humans. A limited number of studies have examined 
specific DURT subsets within bronchoalveolar lavage (BAL) flu-
id, but the relationship between T cells within the bronchoalve-
olar space and the lung parenchyma is unclear (40). Moreover, 
the complexity of examining individual DURT subsets, using 
Discussion
In this study, we took a novel approach to investigating human 
immunity to TB infection by analyzing the DURT and γδ T 
cell response via TCR repertoire sequencing. Importantly, we 
validated this approach by demonstrating a close correlation 
between the frequency of MAITs and γδ T cells identified by flow 
cytometry and the abundance of MAIT and γδ TCR clonotypes in 
the same PBMC samples. Using this technique, we were thus able 
to perform a comprehensive and unbiased characterization of the 
Figure 7. TCRδ clonotypes detected in TB lung granulomas. (A) Cumulative frequency of lung TCRδ clonotypes from 2 representative HIVneg subjects with 
active TB (09-231 and 09-236). Vertical dotted lines indicate the number of clonotypes comprising 50% of the total lung TCRδs. (B) Overlap of TCRδ clono-
types detected in the blood and lung tissue of subjects 09-231 and 09-236. (C) Percentage of lung TCRδ clonotypes detected in the blood (i.e., common to 
blood and lung) for subjects with active TB. (D) Number of TCRδ clonotypes unique to lung samples from subjects 09-231A and 09-236A, shared with blood 
only, shared with other lung samples, or detected in all 3 samples (top pie charts). Relative abundance of the TCRδ clonotypes in these groups (bottom pie 
charts). (E) Groups of TCRδ clonotypes differed in their abundance. Lung frequency of each TCRδ clonotype versus its blood frequency. For clonotypes not 
detected, the frequency was assigned 0.00000011. All unique clonotypes are shown in black. Specific groups of clonotypes are shown in color as follows: 
paired (shared between 1 lung sample and blood; purple); lung-specific (blue); or shared (in all 3 samples; green). Open circles indicate the frequency in 
lung type A lesions; solid circles indicate the frequency in lung type B lesions. Horizontal and vertical lines equal 0.05%. Diagonal is the line of equivalency. 
(F) Identification of abundant and lung-enriched TCRδ clonotypes. For each of 32,000 unique clonotypes from 9 subjects, the sum of the frequencies in 
lung versus the lung/PBMC ratio for each clonotype was plotted. For clonotypes not detected, the frequency was assigned 0.00000011. Abundant and 
enriched clonotypes were defined as having a sum frequency of greater than 0.05% (horizontal dotted line) and a lung/PBMC ratio of greater than 3 (ver-
tical dotted line). Blue represents HIVneg; red represents HIVpos. Bottom left and diagonal boxes indicate clonotypes detected only in blood or lung, and top 
right box indicates 92 abundant and enriched clonotypes. ***P < 0.001, by Student’s t test. Error bars indicate the median.
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active TB and HIV could relate, at least in part, to TCR down 
regulation following antigen encounter. This is supported by 
evidence of recent TCR triggering on the remaining iNKTs 
detected by flow cytometry during active TB (43, 45). In addi-
tion, we found no evidence that iNKTs were relocating to the 
lungs, an idea that has been put forward to explain their loss 
from circulation during active disease (42).
In contrast, the reported loss of circulating MAITs in active 
TB (46–49) is supported by our TCR data, which showed a signif-
icant depletion in both TB- and HIV-TB–coinfected individuals. 
The depletion of circulating MAITs has been hypothesized to be a 
consequence of MAIT cell recruitment to the lungs (8), and T cells 
positive for the Vα7.2 TCR (TRAV1-02) were detected in histologi-
cal sections of TB-infected human lung tissue (46). However, data 
on their frequency in TB-infected lungs are lacking, and the impact 
of HIV on these cells is unknown. HIV results in a profound loss of 
MAITs from both the circulation and the gut mucosa, a loss that 
is not restored by antiretroviral therapy (ART) (30, 50). Similarly, 
SIV infection of NHPs is associated with a reduction of MAITs in 
the blood and BAL fluid (39). Therefore, it is hypothesized that HIV 
also causes a loss of lung-associated MAITs that could contribute to 
tetramers, for example, has meant that studies tend to focus on 
one specificity. In addition, T cell activation can lead to down-
regulation of surface markers that play a role in the identification 
of DURT subsets. MAITs, for example, are typically identified by 
dual surface expression of Vα7.2 TCR (TRAV1-02) and CD161, 
but this latter molecule is downregulated during TCR activation 
(41). Likewise, iNKTs are defined using tetramers or antibodies 
that bind the canonical iNKT Vα24+Vβ11+ TCR, which is down-
regulated when iNKTs encounter their cognate antigen. The 
presence of the canonical DURT TCR DNA rearrangement is not 
affected by the cell activation state and thus, we believe, pres-
ents an unbiased view of T cell frequency.
One possible example of TCR downregulation as a con-
founder of T cell enumeration is illustrated by examining iNKT 
cell frequency. Several studies relying on flow cytometry have 
reported a reduction of iNKTs in the blood of individuals with 
active Mtb or HIV infection compared with that of HCs or indi-
viduals with latent infection (42–45). Our sequence data, how-
ever, showed that the frequency of the iNKT TCR in blood was 
not significantly affected by TB or HIV-TB coinfection. It is pos-
sible, therefore, that the observed reduction of iNKTs during 
Figure 8. Enriched and abundant TCRδ clonotypes. (A) Distribution of CDR3δ lengths based on the relative frequency (left) or abundance (right) of all 
unique clonotypes in blood (top row), lung (middle row), or 92 enriched and abundant clonotypes in the lung (bottom row). Data represent the mean ± 
SEM. (B) Pairing of Vδ1, Vδ2, or Vδ3 with Jδ1, Jδ2, Jδ3, or Jδ4 gene segments for 92 lung-enriched and abundant TCRδ clonotypes. (C) CDR3δ motif for TCRδ 
clonotypes with a CDR3δ length of 19 aa. (D) Distribution of the 92 TCRδ clonotypes between HIVneg or HIVpos subjects with active TB. The numbers indicate 
unique clonotypes. (E) Sharing of unique CDR3δ DNA rearrangements among the 88 blood and lung samples that encoded each unique clonotype. (F) 
Shared clonotypes between different subjects and their relative abundance. Data represent the mean ± SEM.
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These data also provide the opportunity to examine subtle 
differences in the DURT repertoire in a way that is not readily 
possible by conventional approaches. Unlike iNKTs, which are 
defined by an entirely invariant TCR, MAITs and GEMs express 
semi-invariant TCRs that display differences in antigen reactivity 
(16, 37, 52). This could lead to the preferential expansion of cer-
tain clonotypes in response to specific infections or tissue loca-
tions. We found no evidence of skewing of the MAIT or GEM TCR 
repertoire, either in the blood of diseased individuals versus HCs, 
or in the blood versus lungs of subjects with TB. However, the 
observation that several TCRs had GEM-like CDR3α sequences 
that were not derived from the canonical TRAV01-2 chain was 
unexpected. The selection of identical CDR3αs from different 
recombination events suggests that these TCRs are preferentially 
expanded in vivo, presumably because of antigen encounter. The 
GEM clone CAVLNTGGFKTIF, for example, is known to react 
with MA, an essential long-chain mycobacterial lipid, but not with 
the related Mtb antigen GMM (37). The TRAV01-2 recombina-
tion originally described for this CDR3α was detected in only 6 
of 12 blood samples from HCs and in 6 of 49 lung samples from 
patients with TB, in whom it occurred at very low frequency. How-
ever, the CDR3 sequence itself was present at a higher frequency 
in the blood of all HCs and in most TB-infected blood (25 of 27) 
and lung (38 of 49) samples. This therefore confirms that MA- 
reactive GEMs are in fact present in TB-infected lung tissue, but 
they would not have been detected on the basis of their conven-
tional definition or by flow cytometry using TRAV01-2 antibodies 
(37). Likewise, the GMM-reactive CDR3α CAVRNTGGFKTIF was 
present in the blood and lungs of most TB-infected subjects, but 
primarily through non–TRAV01-2 rearrangements. Importantly, 
overall we found no evidence of differences in DURT antigen 
specificity between blood and lung tissue, as previously described 
for conventional Trms (53, 54).
In addition to DURT T cell subsets, this study provided a 
unique opportunity to examine the γδ T cell repertoire in human 
lung tissue. There is growing evidence that γδ T cells play a protec-
tive role in Mtb infection, particularly those γδ T cells expressing 
the Vγ2Vδ2 (also called Vγ9Vδ2) TCR. BCG vaccination expands 
this subset in both adults and infants (55–57), and these T cells can 
directly kill Mtb-infected target cells and enhance conventional T 
cell immunity (21, 58). Moreover, Vγ2Vδ2 T cells are able to rec-
ognize immunogenic phosphoantigens through a novel “inside-
out” mechanism involving butyrophilin 3A1, which can facilitate 
the sensitive detection of intracellular pathogens including Mtb 
(59). Importantly, the Vγ2Vδ2 T cell subset exists only in humans 
and NHPs, but not in mice, which has limited their study (5). 
The peripheral blood TCRδ repertoire in humans is dominated 
by δ2-expressing T cells, which constitute 60%–90% of γδ T cells 
in circulation, and the majority of which are from the Vγ2Vδ2 T 
cell subset (60, 61). Our TCR sequence data agree, as the Vδ2 
chain comprised approximately 60% of the TCRδ repertoire in 
the blood of HCs. Using an anti–δ chain antibody, we detected an 
increase in γδ T cells in the blood of HIVneg subjects with micro-
biologically confirmed pulmonary TB compared with HCs and 
subjects with bacterial pneumonia or other lower respiratory tract 
infections (62). Similar observations were made using Vδ1 and Vδ2 
TCR–specific antibodies (60); and, more recently, an expansion of 
increased TB susceptibility (31). As with iNKTs, we believe our data 
offer the first unbiased look at the impact of TB and HIV-TB infec-
tion on the frequency of MAITs within the human lung. On the 
basis of the experimentally defined MAIT sequences (MAITEXT) 
and an extended definition of MAIT TCRs (MAIT-like), we found 
no evidence of accumulation of MAITs in lung tissue during active 
TB or of the depletion of these cells in HIV-TB–coinfected indi-
viduals. Indeed, the only group with significantly different MAIT 
frequencies was the group of HIV-infected individuals with prior 
TB infection, who possessed more MAITs than expected. Although 
we could not identify clinical features that might explain this MAIT 
enrichment, the observation strongly suggests that HIV infection, 
per se, does not deplete MAITs from the human lung.
The third DURT subset we examined, the group 1 CD1–
restricted T cells, has not been extensively studied in TB-infected 
or HIV-TB–coinfected individuals, in part because of the low fre-
quency of these cells and the lack of phenotypic markers for their 
detection. Enzyme-linked immunospot (ELISpot) assays revealed 
that CD1b-restricted T cells recognizing mycolic acid (MA) were 
enriched in the blood and BAL fluid of subjects with active TB 
compared with that of HCs (51). CD1b and GMM tetramer–stain-
ing T cells, which would include GEMs, were detected in the 
blood of subjects with active TB, but not in that of individuals 
with HIV-TB coinfection (33), although the frequency in TB- 
uninfected individuals was not reported. Here, we show that, 
like MAITs, GEMs were highly depleted from the blood of indi-
viduals with TB infection or HIV-TB coinfection but were not 
enriched in the lungs of these individuals. Indeed, GEMs were 
found to occur at a much lower frequency in the lung than were 
the other DURTs studied and were not detectable in some indi-
viduals. It is possible that GEMs, or indeed any of the DURTS 
investigated here, were elevated at certain stages of TB infec-
tion, either in the blood or the lung, but we found no evidence 
to support this in our chronically infected individuals. Of note, as 
both MAIT and GEM TCRs were depleted from the blood of all 
TB-infected subjects, our data suggest that these DURT subsets 
respond differently to TB and HIV-TB infection compared with 
iNKTs, which were not depleted.
Figure 9. Enriched and abundant TCRδ clonotypes. The 11 TCRδ clono-
types with the highest frequencies in the lungs of subjects with active TB. 
The frequency of each clonotype in the blood and lungs is shown, along 
with the subject number, status, Vδ gene, and CDR3δ aa sequence.
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to Vδ1 (and Vδ3) in the lungs was a broad difference that could 
be observed through flow cytometry. However, the finding that 
most of the TCRδs were unique to the blood or lungs only became 
apparent through sequencing. Moreover, within the same lung, 
the separation of the TCRδ repertoires between different tissue 
sections was remarkable. The apparent propensity of γδ T cells 
to establish Trm populations in nonlymphoid organs and muco-
sal barriers (6) may explain the lack of overlap between blood and 
lung. However, the heterogeneity across lung tissue was surprising 
and suggests that γδ T cells undergo highly localized expansions 
as they encounter antigen. There are several important possible 
implications of this observation. First, and unlike αβ DURTs, there 
is no reason to expect that the antigen specificity of γδ T cells 
detected in the blood will match that of γδ T cells in lung tissue. 
This may be of relevance for studies seeking γδ T cells correlates of 
protection in the blood, or when assessing potential future vaccine 
candidates (11). Second, direct evidence from NHPs and indirect 
evidence from histological examination of human TB-infected 
lung tissue suggests that TB immune control in the lungs is highly 
heterogeneous, as both controlling and progressing TB lesions can 
be simultaneously observed within the same lung (18, 80). Since 
we now know that the γδ T cell repertoire is also extremely het-
erogeneous with the lung, it is plausible that TB granuloma pro-
gression could be influenced by localized expansions of γδ T cells. 
Our identification of highly expanded and enriched or unique lung 
TCRδ clonotypes supports this hypothesis. Single-cell sequencing 
of γδ T cells isolated from individual TB granulomas could further 
test this idea. Locally expanded γδ T cells could then be cloned 
and screened for Mtb reactivity and ultimately be used to identify 
potential γδ T cell vaccine targets (11).
In summary, these data represent a first attempt to describe the 
unconventional T cell landscape of human TB–infected lung tissue 
using high-throughput TCR sequencing. This allowed us to address 
several questions about the recruitment of Mtb-reactive DURTs into 
the human lung during TB and to assess the impact of HIV coinfec-
tion on those cells. In one sense, the relative preservation and even 
distribution of DURTs within the lung, despite HIV coinfection, val-
idate the efforts to elicit these cells with novel vaccine strategies. In 
contrast to DURTs, the extreme discrepancy between the TCRδ rep-
ertoire in blood versus lung and the heterogeneity of this repertoire 
at the site of TB disease are striking. Whether these highly localized 
differences contribute to TB control at the granuloma level remains 
to be determined, but these data suggest that repertoire sequencing 
is a powerful starting point to address these important questions. 
The highly tissue-resident nature of these γδ T cells, as suggested by 
the clear compartmentalization between blood and lung, may repre-
sent a unique opportunity to elicit long-lived and protective Trms at 
the site of disease.
Methods
Participants. TB-infected lung tissue and blood were obtained from 
participants undergoing medically indicated lung resections to treat 
active TB or TB sequelae, including hemoptysis, bronchiectasis, 
shrunken or collapsed lung, or nonresponsive infection at the King 
Dinuzulu Hospital and Inkosi Albert Luthuli Central Hospitals in 
Durban, KwaZulu-Natal. TB-negative control samples were obtained 
from healthy tissue margins from lung cancer resections. Blood from 
γδ T cells detected by flow cytometry was reported in household 
contacts of individuals with TB (63), supporting a potential role for 
these cells in response to primary infection. However, active TB 
has also been linked to a loss of circulating effector Vγ2Vδ2 T cells 
(64), and a progressive loss of these cells correlates with pulmo-
nary disease severity (65). The reason for these disparate results 
is not clear, but the data presented here clearly support a specific 
loss of Vδ2 TCRs from the blood of subjects with severe TB, and 
no overall increase in TCRδ frequency. This is also consistent with 
previous work showing depletion of Vγ2Vδ2 T cells from the blood 
in chronic HIV infection, with limited restoration by ART (66, 67).
As with DURTs, one possible explanation for the loss of Vδ2 
TCRs from the blood could be recruitment to the lungs. Exper-
imentally, a large expansion of γδ T cells expressing Vδ2 was 
observed in both the blood and BAL fluid of NHPs 5 weeks after 
intravenous injection of BCG (23, 58). Aerosol infection of NHPs 
with H37Rv, however, only induced expansion of Vγ2Vδ2 T cells 
in the lungs (up to 23% of all CD3+ T cells) and not in the blood, 
suggesting that the route of infection is key (62, 68). The involve-
ment of γδ T cells, and Vγ2Vδ2 T cells specifically, at the site of dis-
ease in humans has not, however, been well studied. TB-reactive 
γδ T cells were found to be severely depleted in BAL fluid of sub-
jects with active TB compared with that of HCs or of subjects with 
non-TB lung granulomatous disease (69); and Vδ2 T cells were 
significantly less frequent in the BAL fluid of subjects with active 
TB compared with matched blood (70). Taken together, these lim-
ited studies broadly support our own findings, in that the overall 
frequency of TCRδs was not different between the blood and the 
lungs, but the frequency of Vδ2 TCRs in general was much lower in 
the lung than in the blood. Moreover, the loss of Vδ2 T cells in the 
blood was not associated with a reciprocal expansion in the lung in 
subjects with progressive TB.
It is interesting that Vδ1 dominates the lung γδ repertoire, as 
this chain is found at a relatively low frequency in the blood (71). 
An enrichment of Vδ1 in the mucosal epithelium of the intestines, 
lungs, and genital tract has been described previously (71, 72), 
suggesting a role for these cells at barrier sites. In mice, special-
ized intraepithelial lymphocytes (IELs) exclusively express the 
Vδ1 TCR and populate epithelial barriers early during develop-
ment (73). Vδ1+ T cells are activated by various ligands, including 
stress-induced self-antigens and glycolipids presented by CD1c or 
CD1d and others that remain unidentified (74). Functionally, Vδ1+ 
T cells play different roles, depending on the disease context. They 
are the dominant subset in breast tumors and can actively sup-
press effector T cell functions and block DC maturation (75, 76). 
Given that γδ T cell infiltration is directly correlated with tumor 
progression and poor patient outcome, this infiltration could be 
important (77). Vδ1+ T cells also accumulate in the synovial fluid 
of subjects with Lyme arthritis, whereby these cells limit CD4+ T 
cell responses against the causative agent Borrelia burgdorferi (78). 
Finally, Vδ1+ T cells are an important source of IL-17 during the 
response to lung bacterial infection in murine models (79). Given 
the abundance of Vδ1 T cells, understanding their function in the 
TB-infected human lung will be important.
Perhaps the most surprising observation revealed by this 
study was the impressive lack of overlap between γδ T cells in the 
blood and lungs. The shift in dominance from Vδ2 in the blood 
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codons) and TCR gene segment assignment were done as part of the 
ImmunoSEQ assay. Throughout our analysis, we applied the following 
filters: frame = in and reads >1. In most of our analyses, we stated TCR 
frequencies as a percentage of total productive rearrangements. In the 
violin plots, the metric of productive TCR frequency, as a fraction of 
1, was used. MAIT Match Server (http://www.cbs.dtu.dk/services/
MAIT_Match/) was used to identify additional TCRs with MAIT-like 
features (16). BioVenn (http://www.biovenn.nl) was used to compare 
overlapping sets of TCRs (83), and CDR3 motifs were generated using 
WebLogo 3 (http://weblogo.threeplusone.com) (84).
Statistics. Data are presented as the mean ± SEM. A 2-tailed Stu-
dent’s t test was used for normally distributed data for comparisons of 
2 groups. A 1-way or 2-way ANOVA was used for comparison of more 
than 2 groups, followed by Bonferroni’s or Sidak’s post test. A P val-
ue of less than 0.05 was considered statistically significant. Statistical 
and graphical analyses were performed using GraphPad Prism, ver-
sion 8 (GraphPad Software).
Study approval. All participants provided informed consent, and 
the study was approved by the Biomedical Research Ethics Commit-
tee (BREC) of the University of KwaZulu-Natal (BE019/13 for the lung 
cohort and BE 037/13 for the healthy volunteers).
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non–TB-infected controls was obtained from a healthy volunteer 
cohort at the King Edward Hospital in Durban.
PBMC isolation. Blood was collected in BD Vacutainers (sodium 
heparin, BD), PBMCs were isolated using Ficoll-Histopaque (Milli-
poreSigma) density gradient centrifugation and cryopreserved in freez-
ing media (10% DMSO; 90% FCS) until needed. All PBMC samples 
were frozen before use.
Flow cytometry. PBMCs from were thawed in R10 supplemented 
with DNaseI, washed twice by centrifugation (500 g) and rested for 2 
hours at 37°C, 5% CO2, followed by centrifugation and resuspension 
of the pellet in 50 μL antibody mixture for 20 minutes at room tem-
perature. Cells were washed twice (PBS) and fixed with 2% PFA. Cells 
then acquired using an Aria Fusion Cytometer (BD) and analyzed with 
FlowJo Software, version 9.9.6 (Tree Star). The antibody cocktail con-
sisted of LIVE/DEAD Fixable Near-IR Dead Cell Marker (Invitrogen, 
Thermo Fisher Scientific); anti–CD3 Brilliant Violet 785, clone OKT3; 
anti–γδ TCR PE, clone B1; anti–Vδ2 TCR PerCpCy5.5, clone B6; anti–
Vγ9 TCR APC, clone B3; anti–Vα7.2 BV711, clone 3C10; anti–CD26 
PE-Cy5 clone BA5b; anti–CD161 Brilliant Violet 605, clone HP3G10 
(all from BioLegend); anti–CD45 V500, clone HI30 (BD); and anti–
Vδ1 TCR FITC clone TS8.2 (Thermo Fisher Scientific).
Lung processing. For each lung, different areas were removed by the 
operating surgeon and corresponded to the surgeon’s assessment of the 
most diseased (A), intermediate (B), and healthiest tissue (C) tissue on 
the basis of experience and the preoperative radiological data.
DNA extraction. For lung, tissue was added to a 2-mL tube con-
taining 100 μL Zarconia beads (BioSpec) and bead-beaten 5 times 
(7000 rpm for 60 seconds), with 30 seconds on ice between intervals 
using MagNA Lyser (Roche Diagnostics). DNA was extracted from 
snap-frozen lung tissue and PBMCs using a DNeasy Blood and Tissue 
Kit (QIAGEN) according to the manufacturer’s instructions.
Next-generation sequencing and analysis. For TCRα sequencing, 
purified genomic DNA was sequenced by Adaptive Biotechnologies 
using the ImmunoSEQ assay (http://www.immunoseq.com) as pre-
viously described (25). PBMCs were subjected to deep-resolution 
sequencing (identified TCRs with a frequency of 1 in 2 × 105 to 1 × 106), 
and lung samples were subjected to survey resolution (1 in 60,000), 
the rationale being that survey-level sequencing was sufficient for 
identification of expanded TCRs in the lung, but a greater sequenc-
ing depth might be required to identify these TCRs if they were less 
expanded in blood. Data were analyzed using the ImmunoSEQ anal-
yser tools. TCR clonality is a metric related to Shannon’s Diversity 
Index, which measures the diversity and abundance of a cell popu-
lation (81, 82). Productive rearrangements (in-frame without stop 
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